To main content To main navigation

Karina Meijer

Head, Division of Haemostasis and Thrombosis Profile

Head, Division of Haemostasis and Thrombosis

Contact information

Discover our research

Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A

2024, European Journal of Haematology

Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies

All publications

- Aangeboren en verworven stollingsstoornissenKarina Meijer (Speaker) 15-Nov-2022 Professional or public presentation > Professional
- Update behandeling hemofilie: eindelijk ook mabjesKarina Meijer (Speaker) 8-Sep-2022 Professional or public presentation > Professional
- HemoNED (External organisation)Karina Meijer (Member of board) Sep-2022 → Membership > Professional
- Stichting Zorgvernieuwing en Innovatie (External organisation)Karina Meijer (Member of board) Sep-2022 → Membership > Professional
- Low Molecular Weight Heparin Use in Patients with Renal Insufficiency: proposal for an SSC Control of Anticoagulation projectKarina Meijer (Speaker) 10-Jul-2022 Professional or public presentation > Professional
All activities

Contact